3 Result(s)
within
Helena Jernström
Pathology
-
Article
Open AccessRe-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
Human epidermal growth factor receptor 2 (HER2) status in breast cancer is routinely determined through immunohistochemistry (IHC) and/or in situ hybridisation (ISH) performed on whole tissue sections (WS). Th...
-
Article
Open AccessTumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
The mevalonate pathway synthetizes cholesterol, steroid hormones, and non-steriod isoprenoids necessary for cell survival. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is the rate-limiting enzyme of...
-
Article
Open AccessWomen with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
Knowledge is limited regarding the association between stem cells in histologically benign breast tissue and risk factors for breast cancer, and hence we addressed this issue in the present study. Recently, we...
